Formulation Development and Evaluation of Emulgel of Clindamycin Phosphate for Effective Treatment of Acne
Abstract
Emulgel have emerged as one of the most interesting topical delivery system as it has dual release control system i.e. gel and emulsion. The topical applications of the drug offers the potential advantages of delivering the drug directly to the site of action and delivering the drug for extended period of time at the effected site that mainly acts at the related regions. The major objective behind this formulation is enhancing the topical delivery of hydrophobic drug (clindamycin phosphate) by formulating clindamycin phosphate emulgel using carbopol 941 as a gelling agent. In addition, light liquid paraffin as oil, tween-20 and span-20 as emulsifiers and propylene glycol as co-surfactant were selected for preparation of emulgel. Clindamycin phosphate is an antibiotic useful for the treatment of a number of infections. It is of the lincosamide class. Clindamycin phosphate is a semi synthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. Topical clindamycin phosphate reduces free fatty acid concentrations on the skin and suppresses the growth of Propionibacterium acnes (Corynebacterium acnes), an anaerobe found in sebaceous glands and follicles. The prepared emulgel were evaluated for their physical appearance, pH determination, viscosity, spreadability, extrudability, in vitro drug release, anti acne activity and stability. All the prepared emulgel showed acceptable physical properties, homogeneity, consistency, spreadability, viscosity and pH value. The best formulation F4 showed better antiacne activity when compared with all formulation.
Keywords: Emulgel, Clindamycin phosphate, Extrudability, Spreadability, Antiacne activity
Downloads

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).